ClinVar Miner

Submissions for variant NM_001035.3(RYR2):c.568A>G (p.Arg190Gly) (rs794728814)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000182858 SCV000235246 pathogenic not provided 2011-07-22 criteria provided, single submitter clinical testing This mutation is denoted Arg190Gly (aka R190G) at the protein level and c.568 A>G at the cDNA level. The Arg190Gly mutation in the RYR2 gene has not been reported previously as a disease-causing mutation nor as a benign polymorphism, to our knowledge. Arg190Gly results in a non-conservative amino acid substitution of a positively charged Arginine with a non-polar Glycine at a residue that is highly conserved across species. In silico analysis predicts Arg190Gly is probably damaging to the protein structure/function (Adzhubei, et al. 2010). In addition, Arg190Gly is located in the N-terminal mutation hot spot in the RYR2 gene, and mutations in nearby codons (Val186Met, Glu189Asp) have also been reported in association with CPVT, further supporting the functional importance of this region of the protein (Medeiros-Domingo, et al. 2009). Furthermore, Arg190Gly was not detected in up to 600 alleles from control individuals of Caucasian and African American ancestry tested at GeneDx, indicating it is not a common benign variant in these populations. The variant is found in CPVT panel(s).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.